Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

8.250 +0.190 (+2.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful
Coramitug was initially developed by Prothena and was acquired by Novo Nordisk in July 2021. 
Via Stocktwits
Topics Earnings
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy
From Prothena Corporation plc
Via Business Wire
Prothena Q2 Revenue Drops 97%
Via The Motley Fool
Topics Intellectual Property
9 Analysts Assess Prothena Corp: What You Need To Know
 
Via Benzinga
Earnings Scheduled For August 4, 2025
 
Via Benzinga
A Glimpse of Prothena Corp's Earnings Potential
 
Via Benzinga
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights
From Prothena Corporation plc
Via Business Wire
Prothena to Report Second Quarter 2025 Financial Results on August 4
From Prothena Corporation plc
Via Business Wire
8 Analysts Assess Prothena Corp: What You Need To Know
 
Via Benzinga
Prothena Shares Get A Boost After Company Slashes Workforce, Lowers 2025 Cash Burn Forecast
The biotech firm expects to end 2025 with nearly $300 million in cash as it pivots to focus on its Alzheimer’s and Parkinson’s pipeline. 
Via Stocktwits
Topics Workforce
Prothena Announces Corporate Restructuring
From Prothena Corporation plc
Via Business Wire
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease
From Prothena Corporation plc
Via Business Wire
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Here are the top movers in Tuesday's session.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Expert Outlook: Prothena Corp Through The Eyes Of 5 Analysts
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Is Prothena Stock Trading Lower On Tuesday?
Prothena halts birtamimab development after Phase 3 trial fails to meet endpoints in AL amyloidosis patients; cost cuts and new focus expected. 
Via Benzinga
US Stocks Likely To Open Higher After S&P 500's Four-Day Fall: 'Market Is Risk-Off,' Says Expert
U.S. stock futures rose on Tuesday after closing lower for the week on Friday. Futures of benchmark indices were trading higher in premarket. 
Via Benzinga
Topics Stocks
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
These stocks are moving in today's after hours session
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Top movers in Friday's after hours session
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint
From Prothena Corporation plc
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.